secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001104659-24-088395
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio completes warrant exchange; 97% of public warrants tendered; remaining to be exchanged Aug 27
--------------------------------------------------------------------------------

- 97.2% of public warrants (6,703,428) and 69% of private warrants (4,080,580) tendered, exchanged for 3,235,184 Class A ordinary shares.
- Warrant amendment grants Company right to mandatory exchange of remaining IPO warrants at 0.27 shares per warrant.
- Post-Offer Exchange set for August 27, 2024; all untendered warrants will be exchanged at 0.27 ratio.
- After exchange, no IPO warrants remain; warrants to be delisted from Nasdaq as of Aug 26, 2024.
- Cantor Fitzgerald served as dealer manager; Alliance Advisors as info agent; CST as exchange agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924088395/0001104659-24-088395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924088395/tm2421034d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-088395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer